Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

BACKGROUND. The incidence of male breast cancer (MBC) continues to rise. The Veterans
Affairs (VA) Central Cancer Registry (VACCR) provides a unique source for the study of …

Male breast cancer remains understudied despite evidence of rising incidence. Using a co-
ordinated multi-centre approach, we present the first large scale biomarker study to define …

Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical
management is based on results obtained from randomized trials conducted in women …

The occurrence of oncogenic alleles can display striking tissue specificity. For example
KRAS mutations are very frequent in pancreatic cancers but relatively rare in melanomas …

OBJECTIVE: To assess the impact of radiation management on male breast cancer (MBC) at
London Regional Cancer Program (LRCP). METHODS AND MATERIALS: Men with a …

Objective: To review presentation, diagnosis, treatment and prognosis of male breast
cancer. Method: A systematic review of the English language literature between 1990 and …

Mutations in the breast cancer susceptibility genes BRCA1, BRCA2, and CHEK2 are known
risk factors for female breast cancer. Mutations in BRCA1 and BRCA2 also are associated …

A vast portion of human disease results when the process of apoptosis is defective.
Disorders resulting from inappropriate cell death range from autoimmune and …